Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INcrease Of VAgal TonE in CHF (INOVATE-HF) - A Randomized Study to Establish the Safety and Efficacy of CardioFit® for the Treatment of Subjects With Heart Failure and Left Ventricular Dysfunction

NCT01303718 is registered in ClinicalTrials.gov with BioControl Medical as lead sponsor.

NCT NCT01303718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INcrease Of VAgal TonE in CHF (INOVATE-HF) - A Randomized Study to Establish the Safety and Efficacy of CardioFit® for the Treatment of Subjects With Heart Failure and Left Ventricular Dysfunction
Lead sponsor
BioControl Medical
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2011
Completion date
December 31, 2015
Enrollment
730 (actual)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, left ventricular dysfunction